https://www.selleckchem.com/pr....oducts/MGCD0103(Moce
7%) ( 0.001). Amongst virally suppressed patients, 20.0% were INRs. Immunological non-response was significantly more likely amongst patients on second-line ART (adjusted odds ratio [aOR] 1.79), those aged 35-45 and ≥ 45 years (aOR 1.15 and 1.50, respectively), males (aOR 2.28) and patients with confirmed TB (aOR 2.49), and was significantly less likely in cases with higher baseline CD4 count (aOR 0.35). CD4 testing subsequent to ART initiation is poorly implemented and there is a notable proportion of patients with
Like
Comment
Share
